Difference between revisions of "Expand Perinatal Treatment and Support for Women with SUDs"
(Imported from text file) |
|||
| (8 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
| − | + | __NOTOC__ Return to [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map]] or [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]] <div class="wiki" id="content_view" style="display: block">__TOC__ | |
| − | + | = Overview = | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | == | ||
| − | |||
| − | + | <span style="display: inline !important; float: none; background-color: rgb(255, 255, 255); color: rgb(34, 34, 34); font-family: sans-serif; font-size: 13.93px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">Most doctors recommend that pregnant women undergo a long-term treatment plan called drug-assisted stabilization using methadone, also known as harm reduction therapy. This treatment remains sustainable for a woman after she has given birth, because it's covered under Medicaid, so new mothers can still access the treatment, even after their six-week Medicaid-provided postnatal care is done. The treatment also doesn't subject a woman's mind and body through the stress of full withdrawal, allowing her to focus on caring for herself and her baby.</span> | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | * Perinatal: Average gestational age is over 38 weeks; Average birthweight in the normal range | + | = Key Information = |
| − | * Decreased NAS treatment rate | + | |
| − | * Decreased neonatal LOS | + | = Relevant Research = |
| − | * Effective use of technology for screening | + | |
| − | * 2/3 of participants remain in treatment postpartum | + | = Impactful Federal, State, and Local Policies = |
| − | + | ||
| − | ==Centering Pregnancy== | + | = Promising Practices = |
| − | + | ||
| − | =Tools & Resources= | + | == Perinatal Addiction Treatment Program == |
| − | [[TR - Expand Perinatal Treatment for Women with SUDs]] | + | |
| − | = | + | <br/> '''[https://geiselmed.dartmouth.edu/psych/care/dhmc_services/perinatal/ Perinatal Addiction Treatment Program] - Dartmouth Hitchcock Medical Center'''<br/> ''Program Highlights'' |
| − | + | ||
| − | + | *Integrated Care Model: Includes maternity care, substance use treatment, behavioral health/psychiatry, pediatrics | |
| − | + | *Participant Drive Design | |
| − | + | *Private setting 10 minutes from hospital campus | |
| − | + | *Tablet-based [http://www.integration.samhsa.gov/clinical-practice/SBIRT SBIRT] screening | |
| − | + | *18 week parenting class | |
| − | + | ||
| − | + | ''Outcome Successes'' | |
| − | + | ||
| − | + | *Perinatal: Average gestational age is over 38 weeks; Average birthweight in the normal range | |
| − | + | *Decreased NAS treatment rate | |
| − | + | *Decreased neonatal LOS | |
| − | + | *Effective use of technology for screening | |
| − | + | *2/3 of participants remain in treatment postpartum | |
| + | |||
| + | == Centering Pregnancy == | ||
| + | <div class="_">While not specifically focusing on issues of addiction or substance misuse among pregnant women, the [https://www.centeringhealthcare.org/what-we-do/centering-pregnancy CenteringPregnancy] approach has the potential to cost-effectively improve prenatal and perinatal care among women who may be using or be addicted to opioids or other substances. It is a group approach to prenatal and perinatal care. </div> | ||
| + | = Available Tools and Resources = | ||
| + | |||
| + | [[TR_-_Expand_Perinatal_Treatment_for_Women_with_SUDs|TR - Expand Perinatal Treatment for Women with SUDs]] | ||
| + | |||
| + | = <br/> Sources = | ||
| + | </div> | ||
| + | [[Category:SAFE-Treatment and Recovery]] | ||
Latest revision as of 16:52, 8 February 2021
Return to Opioid Top-Level Strategy Map or ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use
Contents
Overview
Most doctors recommend that pregnant women undergo a long-term treatment plan called drug-assisted stabilization using methadone, also known as harm reduction therapy. This treatment remains sustainable for a woman after she has given birth, because it's covered under Medicaid, so new mothers can still access the treatment, even after their six-week Medicaid-provided postnatal care is done. The treatment also doesn't subject a woman's mind and body through the stress of full withdrawal, allowing her to focus on caring for herself and her baby.
Key Information
Relevant Research
Impactful Federal, State, and Local Policies
Promising Practices
Perinatal Addiction Treatment Program
Perinatal Addiction Treatment Program - Dartmouth Hitchcock Medical Center
Program Highlights
- Integrated Care Model: Includes maternity care, substance use treatment, behavioral health/psychiatry, pediatrics
- Participant Drive Design
- Private setting 10 minutes from hospital campus
- Tablet-based SBIRT screening
- 18 week parenting class
Outcome Successes
- Perinatal: Average gestational age is over 38 weeks; Average birthweight in the normal range
- Decreased NAS treatment rate
- Decreased neonatal LOS
- Effective use of technology for screening
- 2/3 of participants remain in treatment postpartum
Centering Pregnancy
While not specifically focusing on issues of addiction or substance misuse among pregnant women, the CenteringPregnancy approach has the potential to cost-effectively improve prenatal and perinatal care among women who may be using or be addicted to opioids or other substances. It is a group approach to prenatal and perinatal care.
Available Tools and Resources
TR - Expand Perinatal Treatment for Women with SUDs
